| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 33.402 | 39.404 | 0 | 6.192 | 0 | 0 | 0 | - | - |
| Total Income - EUR | - | 33.402 | 39.404 | 0 | 6.192 | 2.001 | 0 | 0 | - | - |
| Total Expenses - EUR | - | 704 | 5.725 | 1.627 | 477 | 130 | 51 | 197 | - | - |
| Gross Profit/Loss - EUR | - | 32.697 | 33.679 | -1.627 | 5.715 | 1.871 | -51 | -197 | - | - |
| Net Profit/Loss - EUR | - | 31.695 | 33.285 | -1.627 | 5.529 | 1.871 | -51 | -197 | - | - |
| Employees | - | 1 | 1 | 1 | 0 | 0 | 0 | 0 | - | - |
Check the financial reports for the company - Ermafa Medical Ro S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 67 | 0 | 0 | 0 | 2.207 | 2.158 | 2.164 | - | - |
| Current Assets | - | 32.370 | 67.122 | 64.999 | 5.580 | 5.344 | 5.174 | 5.064 | - | - |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Receivables | - | 28.154 | 14.161 | 13.901 | 28 | 28 | 19 | 154 | - | - |
| Cash | - | 4.216 | 52.961 | 51.098 | 5.551 | 5.317 | 5.155 | 4.911 | - | - |
| Shareholders Funds | - | 31.740 | 64.488 | 61.677 | 5.580 | 7.510 | 7.292 | 7.117 | - | - |
| Social Capital | - | 45 | 44 | 43 | 42 | 207 | 202 | 203 | - | - |
| Debts | - | 697 | 2.634 | 3.322 | 0 | 41 | 40 | 112 | - | - |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2511 - 2511" | |||||||||
| CAEN Financial Year |
2511
|
|||||||||
Comments - Ermafa Medical Ro S.r.l.